Isolation is reported of the four mutant proteins of the
electron-transfer protein rubredoxin from
Clostridium
pasteurianum in which each of the
four cysteine ligands is changed in turn to serine. They
fall
into two pairs whose properties depend on whether an interior (C6, C39)
or a surface (C9, C42) cysteine
ligand is substituted. A crystal structure of the oxidized C42S
protein (1.65 Å; R, 18.5%) confirms the
presence
of an
FeIII(Sγ-Cys)3(Oγ-Ser)
center (Fe−O, 1.82(8) Å). Significant structural change is
restricted to the region
around the mutation. EXAFS experiments confirm
FeIIIS3O (O = Oγ-Ser or
OH
x
) centers in each oxidized
protein at pH 8. The reduction potentials of the
FeIII/II couple are decreased by about 100 and 200
mV,
respectively, in the interior and surface ligand mutants. The
potentials are pH-dependent with respective
pK
a
red
values of about 9 and 7. EXAFS data indicate an increase of
0.2−0.3 Å in the FeII−O distances in
passing
through these characteristic pK
a
red
values. 1H NMR experiments on CdII forms
reveal the presence of CdII(S-Cys)3{O(H)-Ser} centers in the surface ligand
mutants C9S and C42S by the detection of
113Cd−O−CHβ
2
coupling and S−OHγ resonances. The assumption of
the presence of FeII(S-Cys)3(O-Ser)
centers in each
mutant protein at pH values above the characteristic
pK
a
red allows a simple
interpretation of the electrochemical
behavior. Protonation of the Fe−Oγ-Ser link upon
reduction is proposed, followed by hydrolysis at lower pH
values: FeIII−Oγ-Ser + H+
+ e- →
FeII−Oγ(H)-Ser;
FeII−Oγ(H)-Ser + H2O →
FeII−OH2 + HOγ-Ser.
The
differences in reduction potentials, their pH dependence, and the onset
of irreversible electrochemistry can be
attributed to differences in the Fe−O bonds of the interior and
surface ligands. These differences appear to
result from variation in the conformational flexibility of the protein
chelate loops which carry the ligands. An
attempt to generate crystals of the reduced FeII-C42S
protein by treatment of FeIII-C42S crystals with
dithionite
at pH 4 led to loss of iron. A crystal structure (1.6 Å;
R, 16.8%) reveals that cysteine residues 6 and 9
have
trapped the oxidation product SO2, a result confirmed by
reactions in solution: Cys-SH + SO2 →
Cys-SII−SIVO2
- +
H+.
Redox reaction volumes, obtained by high-pressure cyclic voltammetry, are reported for a selection tris(diimine), tris(diamine), hexaammine, and hexaaqua couples of Fe(III/II), Cr(III/II), Ru(III/II), and Co(III/II). Separation of the intrinsic and electrostrictive volume contributions for these couples has been achieved, some in both aqueous and acetonitrile solutions. For the Co(phen)(3)(3+/2+) system, the intrinsic volume change is estimated to be +15.3 +/- 2.1 cm(3) mol(-)(1) (based on measurements in water) and +16.5 +/- 2.0 cm(3) mol(-)(1) (in acetonitrile). For the Co(bipy)(3)(3+/2+) system, values are +12.7 +/- 1.4 cm(3) mol(-)(1) (in water) and +15.5 +/- 2.5 cm(3) mol(-)(1) (in acetonitrile). Using these experimentally determined intrinsic contributions, a simple structural model suggests that the intrinsic volume change for these reactions can be described using the change in effective volume of a sphere with radius close to that of the coordinating-atom-metal bond length. Electrostrictive volume changes for the 3+/2+ complex-ion couples are a function of solute size and coordinated ligands. For Ru(H(2)O)(6)(3+) and Fe(H(2)O)(6)(3+) reduction, volume behavior is significantly different from that of the other systems studied and can be rationalized in terms of possible H-bonding interactions with surrounding solvent which affect the electrostrictive volume changes but which are not available for the ammine and other complexes studied.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.